Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer May 20, 2021
MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children’s Hospital, as Company… May 19, 2021
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM’s Market… Apr 29, 2021
MINDCURE Announces Additional Equity Investment in ATMA; Kelsey Ramsden Named to ATMA Board of Directors Apr 8, 2021